Global Anti-Obesity Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview
Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.
This report provides a deep insight into the global Anti-Obesity Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-Obesity Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-Obesity Therapeutics market in any manner.
Global Anti-Obesity Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bristol-Myers Squibb
Eisai Company
FlaxoSithKline plc.
Novo Nordisk
Alizyme
BoehringerIngelheim GmbH
Pfizer
Takeda Pharmaceutical
Rhythm Pharmaceuticals
Shionogi USA
Vivus
Zafgen
Norgine Pharmaceuticals Ltd.
Market Segmentation (by Type)
Centrally Acting Anti-obesity Drugs
Peripherally Acting Anti-obesity Drugs
Market Segmentation (by Application)
Hospital Use
Clinic Use
Household
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-Obesity Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.
This report provides a deep insight into the global Anti-Obesity Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-Obesity Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-Obesity Therapeutics market in any manner.
Global Anti-Obesity Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bristol-Myers Squibb
Eisai Company
FlaxoSithKline plc.
Novo Nordisk
Alizyme
BoehringerIngelheim GmbH
Pfizer
Takeda Pharmaceutical
Rhythm Pharmaceuticals
Shionogi USA
Vivus
Zafgen
Norgine Pharmaceuticals Ltd.
Market Segmentation (by Type)
Centrally Acting Anti-obesity Drugs
Peripherally Acting Anti-obesity Drugs
Market Segmentation (by Application)
Hospital Use
Clinic Use
Household
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Anti-Obesity Therapeutics Market
- Overview of the regional outlook of the Anti-Obesity Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-Obesity Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Anti-Obesity Therapeutics
1.2 Key Market Segments
1.2.1 Anti-Obesity Therapeutics Segment by Type
1.2.2 Anti-Obesity Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-OBESITY THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-Obesity Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anti-Obesity Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-OBESITY THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-Obesity Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Anti-Obesity Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-Obesity Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-Obesity Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-Obesity Therapeutics Sales Sites, Area Served, Product Type
3.6 Anti-Obesity Therapeutics Market Competitive Situation and Trends
3.6.1 Anti-Obesity Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-Obesity Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-OBESITY THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Anti-Obesity Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-OBESITY THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-OBESITY THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-Obesity Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Anti-Obesity Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Anti-Obesity Therapeutics Price by Type (2019-2024)
7 ANTI-OBESITY THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-Obesity Therapeutics Market Sales by Application (2019-2024)
7.3 Global Anti-Obesity Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-Obesity Therapeutics Sales Growth Rate by Application (2019-2024)
8 ANTI-OBESITY THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Anti-Obesity Therapeutics Sales by Region
8.1.1 Global Anti-Obesity Therapeutics Sales by Region
8.1.2 Global Anti-Obesity Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-Obesity Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-Obesity Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-Obesity Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-Obesity Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-Obesity Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bristol-Myers Squibb
9.1.1 Bristol-Myers Squibb Anti-Obesity Therapeutics Basic Information
9.1.2 Bristol-Myers Squibb Anti-Obesity Therapeutics Product Overview
9.1.3 Bristol-Myers Squibb Anti-Obesity Therapeutics Product Market Performance
9.1.4 Bristol-Myers Squibb Business Overview
9.1.5 Bristol-Myers Squibb Anti-Obesity Therapeutics SWOT Analysis
9.1.6 Bristol-Myers Squibb Recent Developments
9.2 Eisai Company
9.2.1 Eisai Company Anti-Obesity Therapeutics Basic Information
9.2.2 Eisai Company Anti-Obesity Therapeutics Product Overview
9.2.3 Eisai Company Anti-Obesity Therapeutics Product Market Performance
9.2.4 Eisai Company Business Overview
9.2.5 Eisai Company Anti-Obesity Therapeutics SWOT Analysis
9.2.6 Eisai Company Recent Developments
9.3 FlaxoSithKline plc.
9.3.1 FlaxoSithKline plc. Anti-Obesity Therapeutics Basic Information
9.3.2 FlaxoSithKline plc. Anti-Obesity Therapeutics Product Overview
9.3.3 FlaxoSithKline plc. Anti-Obesity Therapeutics Product Market Performance
9.3.4 FlaxoSithKline plc. Anti-Obesity Therapeutics SWOT Analysis
9.3.5 FlaxoSithKline plc. Business Overview
9.3.6 FlaxoSithKline plc. Recent Developments
9.4 Novo Nordisk
9.4.1 Novo Nordisk Anti-Obesity Therapeutics Basic Information
9.4.2 Novo Nordisk Anti-Obesity Therapeutics Product Overview
9.4.3 Novo Nordisk Anti-Obesity Therapeutics Product Market Performance
9.4.4 Novo Nordisk Business Overview
9.4.5 Novo Nordisk Recent Developments
9.5 Alizyme
9.5.1 Alizyme Anti-Obesity Therapeutics Basic Information
9.5.2 Alizyme Anti-Obesity Therapeutics Product Overview
9.5.3 Alizyme Anti-Obesity Therapeutics Product Market Performance
9.5.4 Alizyme Business Overview
9.5.5 Alizyme Recent Developments
9.6 BoehringerIngelheim GmbH
9.6.1 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Basic Information
9.6.2 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Product Overview
9.6.3 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Product Market Performance
9.6.4 BoehringerIngelheim GmbH Business Overview
9.6.5 BoehringerIngelheim GmbH Recent Developments
9.7 Pfizer
9.7.1 Pfizer Anti-Obesity Therapeutics Basic Information
9.7.2 Pfizer Anti-Obesity Therapeutics Product Overview
9.7.3 Pfizer Anti-Obesity Therapeutics Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 Takeda Pharmaceutical
9.8.1 Takeda Pharmaceutical Anti-Obesity Therapeutics Basic Information
9.8.2 Takeda Pharmaceutical Anti-Obesity Therapeutics Product Overview
9.8.3 Takeda Pharmaceutical Anti-Obesity Therapeutics Product Market Performance
9.8.4 Takeda Pharmaceutical Business Overview
9.8.5 Takeda Pharmaceutical Recent Developments
9.9 Rhythm Pharmaceuticals
9.9.1 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Basic Information
9.9.2 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Product Overview
9.9.3 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Product Market Performance
9.9.4 Rhythm Pharmaceuticals Business Overview
9.9.5 Rhythm Pharmaceuticals Recent Developments
9.10 Shionogi USA
9.10.1 Shionogi USA Anti-Obesity Therapeutics Basic Information
9.10.2 Shionogi USA Anti-Obesity Therapeutics Product Overview
9.10.3 Shionogi USA Anti-Obesity Therapeutics Product Market Performance
9.10.4 Shionogi USA Business Overview
9.10.5 Shionogi USA Recent Developments
9.11 Vivus
9.11.1 Vivus Anti-Obesity Therapeutics Basic Information
9.11.2 Vivus Anti-Obesity Therapeutics Product Overview
9.11.3 Vivus Anti-Obesity Therapeutics Product Market Performance
9.11.4 Vivus Business Overview
9.11.5 Vivus Recent Developments
9.12 Zafgen
9.12.1 Zafgen Anti-Obesity Therapeutics Basic Information
9.12.2 Zafgen Anti-Obesity Therapeutics Product Overview
9.12.3 Zafgen Anti-Obesity Therapeutics Product Market Performance
9.12.4 Zafgen Business Overview
9.12.5 Zafgen Recent Developments
9.13 Norgine Pharmaceuticals Ltd.
9.13.1 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Basic Information
9.13.2 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Product Overview
9.13.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Product Market Performance
9.13.4 Norgine Pharmaceuticals Ltd. Business Overview
9.13.5 Norgine Pharmaceuticals Ltd. Recent Developments
10 ANTI-OBESITY THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Anti-Obesity Therapeutics Market Size Forecast
10.2 Global Anti-Obesity Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti-Obesity Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Anti-Obesity Therapeutics Market Size Forecast by Region
10.2.4 South America Anti-Obesity Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anti-Obesity Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Anti-Obesity Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anti-Obesity Therapeutics by Type (2025-2030)
11.1.2 Global Anti-Obesity Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anti-Obesity Therapeutics by Type (2025-2030)
11.2 Global Anti-Obesity Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Anti-Obesity Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Anti-Obesity Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Anti-Obesity Therapeutics
1.2 Key Market Segments
1.2.1 Anti-Obesity Therapeutics Segment by Type
1.2.2 Anti-Obesity Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-OBESITY THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-Obesity Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anti-Obesity Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-OBESITY THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-Obesity Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Anti-Obesity Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-Obesity Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-Obesity Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-Obesity Therapeutics Sales Sites, Area Served, Product Type
3.6 Anti-Obesity Therapeutics Market Competitive Situation and Trends
3.6.1 Anti-Obesity Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-Obesity Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-OBESITY THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Anti-Obesity Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-OBESITY THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-OBESITY THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-Obesity Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Anti-Obesity Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Anti-Obesity Therapeutics Price by Type (2019-2024)
7 ANTI-OBESITY THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-Obesity Therapeutics Market Sales by Application (2019-2024)
7.3 Global Anti-Obesity Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-Obesity Therapeutics Sales Growth Rate by Application (2019-2024)
8 ANTI-OBESITY THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Anti-Obesity Therapeutics Sales by Region
8.1.1 Global Anti-Obesity Therapeutics Sales by Region
8.1.2 Global Anti-Obesity Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-Obesity Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-Obesity Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-Obesity Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-Obesity Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-Obesity Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bristol-Myers Squibb
9.1.1 Bristol-Myers Squibb Anti-Obesity Therapeutics Basic Information
9.1.2 Bristol-Myers Squibb Anti-Obesity Therapeutics Product Overview
9.1.3 Bristol-Myers Squibb Anti-Obesity Therapeutics Product Market Performance
9.1.4 Bristol-Myers Squibb Business Overview
9.1.5 Bristol-Myers Squibb Anti-Obesity Therapeutics SWOT Analysis
9.1.6 Bristol-Myers Squibb Recent Developments
9.2 Eisai Company
9.2.1 Eisai Company Anti-Obesity Therapeutics Basic Information
9.2.2 Eisai Company Anti-Obesity Therapeutics Product Overview
9.2.3 Eisai Company Anti-Obesity Therapeutics Product Market Performance
9.2.4 Eisai Company Business Overview
9.2.5 Eisai Company Anti-Obesity Therapeutics SWOT Analysis
9.2.6 Eisai Company Recent Developments
9.3 FlaxoSithKline plc.
9.3.1 FlaxoSithKline plc. Anti-Obesity Therapeutics Basic Information
9.3.2 FlaxoSithKline plc. Anti-Obesity Therapeutics Product Overview
9.3.3 FlaxoSithKline plc. Anti-Obesity Therapeutics Product Market Performance
9.3.4 FlaxoSithKline plc. Anti-Obesity Therapeutics SWOT Analysis
9.3.5 FlaxoSithKline plc. Business Overview
9.3.6 FlaxoSithKline plc. Recent Developments
9.4 Novo Nordisk
9.4.1 Novo Nordisk Anti-Obesity Therapeutics Basic Information
9.4.2 Novo Nordisk Anti-Obesity Therapeutics Product Overview
9.4.3 Novo Nordisk Anti-Obesity Therapeutics Product Market Performance
9.4.4 Novo Nordisk Business Overview
9.4.5 Novo Nordisk Recent Developments
9.5 Alizyme
9.5.1 Alizyme Anti-Obesity Therapeutics Basic Information
9.5.2 Alizyme Anti-Obesity Therapeutics Product Overview
9.5.3 Alizyme Anti-Obesity Therapeutics Product Market Performance
9.5.4 Alizyme Business Overview
9.5.5 Alizyme Recent Developments
9.6 BoehringerIngelheim GmbH
9.6.1 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Basic Information
9.6.2 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Product Overview
9.6.3 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Product Market Performance
9.6.4 BoehringerIngelheim GmbH Business Overview
9.6.5 BoehringerIngelheim GmbH Recent Developments
9.7 Pfizer
9.7.1 Pfizer Anti-Obesity Therapeutics Basic Information
9.7.2 Pfizer Anti-Obesity Therapeutics Product Overview
9.7.3 Pfizer Anti-Obesity Therapeutics Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 Takeda Pharmaceutical
9.8.1 Takeda Pharmaceutical Anti-Obesity Therapeutics Basic Information
9.8.2 Takeda Pharmaceutical Anti-Obesity Therapeutics Product Overview
9.8.3 Takeda Pharmaceutical Anti-Obesity Therapeutics Product Market Performance
9.8.4 Takeda Pharmaceutical Business Overview
9.8.5 Takeda Pharmaceutical Recent Developments
9.9 Rhythm Pharmaceuticals
9.9.1 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Basic Information
9.9.2 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Product Overview
9.9.3 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Product Market Performance
9.9.4 Rhythm Pharmaceuticals Business Overview
9.9.5 Rhythm Pharmaceuticals Recent Developments
9.10 Shionogi USA
9.10.1 Shionogi USA Anti-Obesity Therapeutics Basic Information
9.10.2 Shionogi USA Anti-Obesity Therapeutics Product Overview
9.10.3 Shionogi USA Anti-Obesity Therapeutics Product Market Performance
9.10.4 Shionogi USA Business Overview
9.10.5 Shionogi USA Recent Developments
9.11 Vivus
9.11.1 Vivus Anti-Obesity Therapeutics Basic Information
9.11.2 Vivus Anti-Obesity Therapeutics Product Overview
9.11.3 Vivus Anti-Obesity Therapeutics Product Market Performance
9.11.4 Vivus Business Overview
9.11.5 Vivus Recent Developments
9.12 Zafgen
9.12.1 Zafgen Anti-Obesity Therapeutics Basic Information
9.12.2 Zafgen Anti-Obesity Therapeutics Product Overview
9.12.3 Zafgen Anti-Obesity Therapeutics Product Market Performance
9.12.4 Zafgen Business Overview
9.12.5 Zafgen Recent Developments
9.13 Norgine Pharmaceuticals Ltd.
9.13.1 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Basic Information
9.13.2 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Product Overview
9.13.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Product Market Performance
9.13.4 Norgine Pharmaceuticals Ltd. Business Overview
9.13.5 Norgine Pharmaceuticals Ltd. Recent Developments
10 ANTI-OBESITY THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Anti-Obesity Therapeutics Market Size Forecast
10.2 Global Anti-Obesity Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti-Obesity Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Anti-Obesity Therapeutics Market Size Forecast by Region
10.2.4 South America Anti-Obesity Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anti-Obesity Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Anti-Obesity Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anti-Obesity Therapeutics by Type (2025-2030)
11.1.2 Global Anti-Obesity Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anti-Obesity Therapeutics by Type (2025-2030)
11.2 Global Anti-Obesity Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Anti-Obesity Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Anti-Obesity Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-Obesity Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Anti-Obesity Therapeutics Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Anti-Obesity Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-Obesity Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-Obesity Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Therapeutics as of 2022)
Table 10. Global Market Anti-Obesity Therapeutics Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-Obesity Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Anti-Obesity Therapeutics Product Type
Table 13. Global Anti-Obesity Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-Obesity Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-Obesity Therapeutics Market Challenges
Table 22. Global Anti-Obesity Therapeutics Sales by Type (Kilotons)
Table 23. Global Anti-Obesity Therapeutics Market Size by Type (M USD)
Table 24. Global Anti-Obesity Therapeutics Sales (Kilotons) by Type (2019-2024)
Table 25. Global Anti-Obesity Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Anti-Obesity Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-Obesity Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Anti-Obesity Therapeutics Price (USD/Ton) by Type (2019-2024)
Table 29. Global Anti-Obesity Therapeutics Sales (Kilotons) by Application
Table 30. Global Anti-Obesity Therapeutics Market Size by Application
Table 31. Global Anti-Obesity Therapeutics Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Anti-Obesity Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Anti-Obesity Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-Obesity Therapeutics Market Share by Application (2019-2024)
Table 35. Global Anti-Obesity Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-Obesity Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Anti-Obesity Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Anti-Obesity Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Anti-Obesity Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Anti-Obesity Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Anti-Obesity Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Anti-Obesity Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 43. Bristol-Myers Squibb Anti-Obesity Therapeutics Basic Information
Table 44. Bristol-Myers Squibb Anti-Obesity Therapeutics Product Overview
Table 45. Bristol-Myers Squibb Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bristol-Myers Squibb Business Overview
Table 47. Bristol-Myers Squibb Anti-Obesity Therapeutics SWOT Analysis
Table 48. Bristol-Myers Squibb Recent Developments
Table 49. Eisai Company Anti-Obesity Therapeutics Basic Information
Table 50. Eisai Company Anti-Obesity Therapeutics Product Overview
Table 51. Eisai Company Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Eisai Company Business Overview
Table 53. Eisai Company Anti-Obesity Therapeutics SWOT Analysis
Table 54. Eisai Company Recent Developments
Table 55. FlaxoSithKline plc. Anti-Obesity Therapeutics Basic Information
Table 56. FlaxoSithKline plc. Anti-Obesity Therapeutics Product Overview
Table 57. FlaxoSithKline plc. Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. FlaxoSithKline plc. Anti-Obesity Therapeutics SWOT Analysis
Table 59. FlaxoSithKline plc. Business Overview
Table 60. FlaxoSithKline plc. Recent Developments
Table 61. Novo Nordisk Anti-Obesity Therapeutics Basic Information
Table 62. Novo Nordisk Anti-Obesity Therapeutics Product Overview
Table 63. Novo Nordisk Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Novo Nordisk Business Overview
Table 65. Novo Nordisk Recent Developments
Table 66. Alizyme Anti-Obesity Therapeutics Basic Information
Table 67. Alizyme Anti-Obesity Therapeutics Product Overview
Table 68. Alizyme Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Alizyme Business Overview
Table 70. Alizyme Recent Developments
Table 71. BoehringerIngelheim GmbH Anti-Obesity Therapeutics Basic Information
Table 72. BoehringerIngelheim GmbH Anti-Obesity Therapeutics Product Overview
Table 73. BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. BoehringerIngelheim GmbH Business Overview
Table 75. BoehringerIngelheim GmbH Recent Developments
Table 76. Pfizer Anti-Obesity Therapeutics Basic Information
Table 77. Pfizer Anti-Obesity Therapeutics Product Overview
Table 78. Pfizer Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Pfizer Business Overview
Table 80. Pfizer Recent Developments
Table 81. Takeda Pharmaceutical Anti-Obesity Therapeutics Basic Information
Table 82. Takeda Pharmaceutical Anti-Obesity Therapeutics Product Overview
Table 83. Takeda Pharmaceutical Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Takeda Pharmaceutical Business Overview
Table 85. Takeda Pharmaceutical Recent Developments
Table 86. Rhythm Pharmaceuticals Anti-Obesity Therapeutics Basic Information
Table 87. Rhythm Pharmaceuticals Anti-Obesity Therapeutics Product Overview
Table 88. Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Rhythm Pharmaceuticals Business Overview
Table 90. Rhythm Pharmaceuticals Recent Developments
Table 91. Shionogi USA Anti-Obesity Therapeutics Basic Information
Table 92. Shionogi USA Anti-Obesity Therapeutics Product Overview
Table 93. Shionogi USA Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Shionogi USA Business Overview
Table 95. Shionogi USA Recent Developments
Table 96. Vivus Anti-Obesity Therapeutics Basic Information
Table 97. Vivus Anti-Obesity Therapeutics Product Overview
Table 98. Vivus Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Vivus Business Overview
Table 100. Vivus Recent Developments
Table 101. Zafgen Anti-Obesity Therapeutics Basic Information
Table 102. Zafgen Anti-Obesity Therapeutics Product Overview
Table 103. Zafgen Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Zafgen Business Overview
Table 105. Zafgen Recent Developments
Table 106. Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Basic Information
Table 107. Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Product Overview
Table 108. Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Norgine Pharmaceuticals Ltd. Business Overview
Table 110. Norgine Pharmaceuticals Ltd. Recent Developments
Table 111. Global Anti-Obesity Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Anti-Obesity Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Anti-Obesity Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Anti-Obesity Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Anti-Obesity Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Anti-Obesity Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Anti-Obesity Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Anti-Obesity Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Anti-Obesity Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Anti-Obesity Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Anti-Obesity Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Anti-Obesity Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Anti-Obesity Therapeutics Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Anti-Obesity Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Anti-Obesity Therapeutics Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Anti-Obesity Therapeutics Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Anti-Obesity Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-Obesity Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Anti-Obesity Therapeutics Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Anti-Obesity Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-Obesity Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-Obesity Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Obesity Therapeutics as of 2022)
Table 10. Global Market Anti-Obesity Therapeutics Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-Obesity Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Anti-Obesity Therapeutics Product Type
Table 13. Global Anti-Obesity Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-Obesity Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-Obesity Therapeutics Market Challenges
Table 22. Global Anti-Obesity Therapeutics Sales by Type (Kilotons)
Table 23. Global Anti-Obesity Therapeutics Market Size by Type (M USD)
Table 24. Global Anti-Obesity Therapeutics Sales (Kilotons) by Type (2019-2024)
Table 25. Global Anti-Obesity Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Anti-Obesity Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-Obesity Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Anti-Obesity Therapeutics Price (USD/Ton) by Type (2019-2024)
Table 29. Global Anti-Obesity Therapeutics Sales (Kilotons) by Application
Table 30. Global Anti-Obesity Therapeutics Market Size by Application
Table 31. Global Anti-Obesity Therapeutics Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Anti-Obesity Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Anti-Obesity Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-Obesity Therapeutics Market Share by Application (2019-2024)
Table 35. Global Anti-Obesity Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-Obesity Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Anti-Obesity Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Anti-Obesity Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Anti-Obesity Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Anti-Obesity Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Anti-Obesity Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Anti-Obesity Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 43. Bristol-Myers Squibb Anti-Obesity Therapeutics Basic Information
Table 44. Bristol-Myers Squibb Anti-Obesity Therapeutics Product Overview
Table 45. Bristol-Myers Squibb Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bristol-Myers Squibb Business Overview
Table 47. Bristol-Myers Squibb Anti-Obesity Therapeutics SWOT Analysis
Table 48. Bristol-Myers Squibb Recent Developments
Table 49. Eisai Company Anti-Obesity Therapeutics Basic Information
Table 50. Eisai Company Anti-Obesity Therapeutics Product Overview
Table 51. Eisai Company Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Eisai Company Business Overview
Table 53. Eisai Company Anti-Obesity Therapeutics SWOT Analysis
Table 54. Eisai Company Recent Developments
Table 55. FlaxoSithKline plc. Anti-Obesity Therapeutics Basic Information
Table 56. FlaxoSithKline plc. Anti-Obesity Therapeutics Product Overview
Table 57. FlaxoSithKline plc. Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. FlaxoSithKline plc. Anti-Obesity Therapeutics SWOT Analysis
Table 59. FlaxoSithKline plc. Business Overview
Table 60. FlaxoSithKline plc. Recent Developments
Table 61. Novo Nordisk Anti-Obesity Therapeutics Basic Information
Table 62. Novo Nordisk Anti-Obesity Therapeutics Product Overview
Table 63. Novo Nordisk Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Novo Nordisk Business Overview
Table 65. Novo Nordisk Recent Developments
Table 66. Alizyme Anti-Obesity Therapeutics Basic Information
Table 67. Alizyme Anti-Obesity Therapeutics Product Overview
Table 68. Alizyme Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Alizyme Business Overview
Table 70. Alizyme Recent Developments
Table 71. BoehringerIngelheim GmbH Anti-Obesity Therapeutics Basic Information
Table 72. BoehringerIngelheim GmbH Anti-Obesity Therapeutics Product Overview
Table 73. BoehringerIngelheim GmbH Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. BoehringerIngelheim GmbH Business Overview
Table 75. BoehringerIngelheim GmbH Recent Developments
Table 76. Pfizer Anti-Obesity Therapeutics Basic Information
Table 77. Pfizer Anti-Obesity Therapeutics Product Overview
Table 78. Pfizer Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Pfizer Business Overview
Table 80. Pfizer Recent Developments
Table 81. Takeda Pharmaceutical Anti-Obesity Therapeutics Basic Information
Table 82. Takeda Pharmaceutical Anti-Obesity Therapeutics Product Overview
Table 83. Takeda Pharmaceutical Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Takeda Pharmaceutical Business Overview
Table 85. Takeda Pharmaceutical Recent Developments
Table 86. Rhythm Pharmaceuticals Anti-Obesity Therapeutics Basic Information
Table 87. Rhythm Pharmaceuticals Anti-Obesity Therapeutics Product Overview
Table 88. Rhythm Pharmaceuticals Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Rhythm Pharmaceuticals Business Overview
Table 90. Rhythm Pharmaceuticals Recent Developments
Table 91. Shionogi USA Anti-Obesity Therapeutics Basic Information
Table 92. Shionogi USA Anti-Obesity Therapeutics Product Overview
Table 93. Shionogi USA Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Shionogi USA Business Overview
Table 95. Shionogi USA Recent Developments
Table 96. Vivus Anti-Obesity Therapeutics Basic Information
Table 97. Vivus Anti-Obesity Therapeutics Product Overview
Table 98. Vivus Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Vivus Business Overview
Table 100. Vivus Recent Developments
Table 101. Zafgen Anti-Obesity Therapeutics Basic Information
Table 102. Zafgen Anti-Obesity Therapeutics Product Overview
Table 103. Zafgen Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Zafgen Business Overview
Table 105. Zafgen Recent Developments
Table 106. Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Basic Information
Table 107. Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Product Overview
Table 108. Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Norgine Pharmaceuticals Ltd. Business Overview
Table 110. Norgine Pharmaceuticals Ltd. Recent Developments
Table 111. Global Anti-Obesity Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Anti-Obesity Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Anti-Obesity Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Anti-Obesity Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Anti-Obesity Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Anti-Obesity Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Anti-Obesity Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Anti-Obesity Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Anti-Obesity Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Anti-Obesity Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Anti-Obesity Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Anti-Obesity Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Anti-Obesity Therapeutics Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Anti-Obesity Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Anti-Obesity Therapeutics Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Anti-Obesity Therapeutics Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Anti-Obesity Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Anti-Obesity Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-Obesity Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Anti-Obesity Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Anti-Obesity Therapeutics Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-Obesity Therapeutics Market Size by Country (M USD)
Figure 11. Anti-Obesity Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Anti-Obesity Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Anti-Obesity Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-Obesity Therapeutics Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-Obesity Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-Obesity Therapeutics Market Share by Type
Figure 18. Sales Market Share of Anti-Obesity Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Anti-Obesity Therapeutics by Type in 2023
Figure 20. Market Size Share of Anti-Obesity Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-Obesity Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-Obesity Therapeutics Market Share by Application
Figure 24. Global Anti-Obesity Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-Obesity Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Anti-Obesity Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Anti-Obesity Therapeutics Market Share by Application in 2023
Figure 28. Global Anti-Obesity Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-Obesity Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Anti-Obesity Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Anti-Obesity Therapeutics Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-Obesity Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Anti-Obesity Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Anti-Obesity Therapeutics Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Anti-Obesity Therapeutics Sales Market Share by Region in 2023
Figure 44. China Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Anti-Obesity Therapeutics Sales and Growth Rate (Kilotons)
Figure 50. South America Anti-Obesity Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Anti-Obesity Therapeutics Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Anti-Obesity Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Anti-Obesity Therapeutics Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Anti-Obesity Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Anti-Obesity Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Anti-Obesity Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Anti-Obesity Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Anti-Obesity Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Anti-Obesity Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-Obesity Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Anti-Obesity Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Anti-Obesity Therapeutics Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-Obesity Therapeutics Market Size by Country (M USD)
Figure 11. Anti-Obesity Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Anti-Obesity Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Anti-Obesity Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-Obesity Therapeutics Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-Obesity Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-Obesity Therapeutics Market Share by Type
Figure 18. Sales Market Share of Anti-Obesity Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Anti-Obesity Therapeutics by Type in 2023
Figure 20. Market Size Share of Anti-Obesity Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-Obesity Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-Obesity Therapeutics Market Share by Application
Figure 24. Global Anti-Obesity Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-Obesity Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Anti-Obesity Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Anti-Obesity Therapeutics Market Share by Application in 2023
Figure 28. Global Anti-Obesity Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-Obesity Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Anti-Obesity Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Anti-Obesity Therapeutics Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-Obesity Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Anti-Obesity Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Anti-Obesity Therapeutics Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Anti-Obesity Therapeutics Sales Market Share by Region in 2023
Figure 44. China Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Anti-Obesity Therapeutics Sales and Growth Rate (Kilotons)
Figure 50. South America Anti-Obesity Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Anti-Obesity Therapeutics Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Anti-Obesity Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Anti-Obesity Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Anti-Obesity Therapeutics Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Anti-Obesity Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Anti-Obesity Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Anti-Obesity Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Anti-Obesity Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Anti-Obesity Therapeutics Market Share Forecast by Application (2025-2030)
